Filing Flows › Comparisons › XLO vs ARCT
Xilio Therapeutics vs Arcturus Therapeutics Holdings: XLO and ARCT compared
Xilio Therapeutics is the larger company: $18.7M of revenue in its latest quarter (Q2 2026) against $18.3M for Arcturus Therapeutics Holdings (Q3 2026). Xilio Therapeutics is growing faster (+131% against +7% a year earlier). Xilio Therapeutics is more profitable, with an operating margin of -18.7% against -50.2%.
Where the money goes: XLO and ARCT
Xilio Therapeutics (XLO) · Q2 2026
Xilio Therapeutics, Q2 2026: revenue $18.7M (+131% year over year), operating margin -18.7%, net loss $6.4M, operating cash flow −$18.8M. The chart follows the revenue to costs, profit and cash.
Arcturus Therapeutics Holdings (ARCT) · Q3 2026
Arcturus Therapeutics Holdings, Q3 2026: revenue $18.3M (+7% year over year), operating margin -50.2%, net loss $7.4M, operating cash flow −$6.9M. The chart follows the revenue to costs, profit and cash.
| Xilio Therapeutics (XLO) | Arcturus Therapeutics Holdings (ARCT) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $18.7M | $18.3M |
| Revenue growth, Y/Y | +131% | +7% |
| Operating margin | -18.7% | -50.2% |
| Net earnings | −$6.4M | −$7.4M |
| Net margin | -34.1% | -40.5% |
| Operating cash flow | −$18.8M | −$6.9M |
Where the revenue comes from
Arcturus Therapeutics Holdings
- Collaboration Revenue: $16.9M (92%)
- Grant: $1.4M (8%)
Questions
Which is bigger, Xilio Therapeutics or Arcturus Therapeutics Holdings?
Xilio Therapeutics is the larger company: $18.7M of revenue in its latest quarter (Q2 2026) against $18.3M for Arcturus Therapeutics Holdings (Q3 2026).
Is Xilio Therapeutics or Arcturus Therapeutics Holdings growing faster?
Xilio Therapeutics is growing faster (+131% against +7% a year earlier).
Which is more profitable, Xilio Therapeutics or Arcturus Therapeutics Holdings?
Xilio Therapeutics is more profitable, with an operating margin of -18.7% against -50.2%.
More: Xilio Therapeutics earnings · how Xilio Therapeutics makes money · Arcturus Therapeutics Holdings earnings · how Arcturus Therapeutics Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 12, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.